Objectives Bisphosphonate‐related osteonecrosis of the jaw (BRONJ) is a severe
complication of systemic nitrogen‐containing bisphosphonate (N‐BP) administration, which …

Background/purpose Bisphosphonate-related osteonecrosis of the jaw (BRONJ), a
complication arising from the use of bisphosphonates (BPs), inflicts long-term suffering on …

The mechanism and effective treatment of bisphosphonate-related osteonecrosis of the jaw
(BRONJ) are still uncertain. Our previous study revealed that zoledronate (ZOL) …

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a serious skeletal complication
associated with the long-term oral or intravenous use of nitrogen-containing …

Purpose Bisphosphonates related osteonecrosis of jaw (BRONJ) is a severe complication of
systemic BPs administration, the mechanism of which is still unclarified. Recently, platelet …

Antiresorptive or antiangiogenic drugs can cause medication-related osteonecrosis of the
jaw that is refractory. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) may be …

Objective Previously published animal investigations on bisphosphonate-related
osteonecrosis of the jaws (BRONJ) showed a variety of methods for BRONJ induction and …

Objective: To establish a rat model of bisphosphonate-related osteonecrosis of the jaw
(BRONJ) that realistically mimics major clinical manifestations of the disease. Methods …

Since the first description of bisphosphonate-related osteonecrosis of the jaw (BRONJ),
numerous research groups have focused on possible pathological mechanisms including …

Bisphosphonate-associated osteonecrosis of the jaws (BP-ONJ) is a side effect primarily in
patients receiving highly potent nitrogen-containing bisphosphonates. The exact …